NYSEAMERICAN:INFU - InfuSystem Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.30 -0.05 (-1.49 %) (As of 11/19/2018 04:46 AM ET)Previous Close$3.30Today's Range$3.30 - $3.4452-Week Range$1.95 - $3.60Volume60,537 shsAverage Volume32,905 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan. Receive INFU News and Ratings via Email Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A Webir.infusystem.com Phone+1-248-2911210 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees234 Outstanding Shares19,540,000Market Cap$0.00 OptionableNot Optionable InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions What is InfuSystem's stock symbol? InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU." How will InfuSystem's stock buyback program work? InfuSystem declared that its Board of Directors has approved a stock buyback program on Tuesday, March 13th 2018, which allows the company to buyback 1,000,000 shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company's management believes its stock is undervalued. How were InfuSystem's earnings last quarter? InfuSystem Holdings Inc (NYSEAMERICAN:INFU) posted its quarterly earnings data on Tuesday, November, 13th. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter. The medical instruments supplier earned $16.68 million during the quarter. View InfuSystem's Earnings History. When is InfuSystem's next earnings date? InfuSystem is scheduled to release their next quarterly earnings announcement on Tuesday, March 12th 2019. View Earnings Estimates for InfuSystem. Has InfuSystem been receiving favorable news coverage? News coverage about INFU stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InfuSystem earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of InfuSystem's key competitors? Some companies that are related to InfuSystem include Advanced Medical Solutions (AMS), Akers Biosciences (AKR), Ansell (ANN), Bovie Medical (BVX), Bovie Medical (BVX), Clover (CLV), CONVATEC Grp PL/ADR (CNVVY), CRH Medical (CRHM), CRH Medical (CRH), Daxor (DXR), Enerplus (ERF), Essilor International Cmgn Gnl D Optq (EI), Gerresheimer (GXI), Iris BioTechnologies (IRSB) and IsoRay (ISR). Who are InfuSystem's key executives? InfuSystem's management team includes the folowing people: Mr. Richard A. DiIorio, Pres, CEO & Director (Age 43)Ms. Janet Skonieczny, Consultant (Age 58)Mr. Christopher S. Downs, Former Exec. VP, Interim CFO & Member of Office of the Pres (Age 39)Mr. Gregory Schulte, Exec. VP & CFO (Age 51)Mr. Tom Ruiz, Sr. VP of Sales & Marketing Who are InfuSystem's major shareholders? InfuSystem's stock is owned by a number of of institutional and retail investors. Top institutional investors include Gabelli Funds LLC (1.75%), Renaissance Technologies LLC (1.53%), FineMark National Bank & Trust (1.09%), Dimensional Fund Advisors LP (1.08%), Gamco Investors INC. ET AL (0.43%) and LSV Asset Management (0.34%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, David C Dreyer, Eric K Steen, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Institutional Ownership Trends for InfuSystem. Which institutional investors are selling InfuSystem stock? INFU stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management and FineMark National Bank & Trust. View Insider Buying and Selling for InfuSystem. Which institutional investors are buying InfuSystem stock? INFU stock was purchased by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Gamco Investors INC. ET AL, Dimensional Fund Advisors LP and Renaissance Technologies LLC. Company insiders that have bought InfuSystem stock in the last two years include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Insider Buying and Selling for InfuSystem. How do I buy shares of InfuSystem? Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is InfuSystem's stock price today? One share of INFU stock can currently be purchased for approximately $3.30. What is InfuSystem's official website? The official website for InfuSystem is http://ir.infusystem.com/. How can I contact InfuSystem? InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210. MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 65 (Vote Outperform)Underperform Votes: 73 (Vote Underperform)Total Votes: 138MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/19/2018 by MarketBeat.com StaffFeatured Article: Why do earnings reports matter?